Clinical trials
Phase 2 Cutaneous Squamous Cell Carcinoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 2 |
| Incyte Corporation | 1 |
| Melanoma Institute Australia | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| Replimune, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 7 |
| Basal Cell Carcinoma | 1 |
| Carcinoma | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Squamous Cell | 1 |
| Endometrial Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Non-Melanoma Skin Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.